How Is Mayo Clinic Using AI in Its Revenue Cycle?
Mayo Clinic is deploying AI across its revenue cycle operations, but revenue cycle chair Todd Manion said he's skeptical that these functions will be fully automated anytime soon.
Mayo Clinic is deploying AI across its revenue cycle operations, but revenue cycle chair Todd Manion said he's skeptical that these functions will be fully automated anytime soon.
AI hasn't solved all the problems plaguing healthcare's revenue cycle — but R1's Lee Kupferman says that it is getting closer, one gray area at a time.
The healthcare industry is spending more than ever on AI — but according to executives from Oracle Health, HCA Healthcare and BJC Health, much of that investment could be wasted. During a panel this week at HFMA’s annual conference, they argued that no amount of sophisticated tech can overcome a broken, antiquated data foundation.
Clinical AI startup Abridge held a New York City event to signal it's done being thought of as just an AI scribe. The company announced a Nvidia foundation model partnership, an Eli Lilly investment, new capabilities for its platform, and the intent to help mediate the relationship between payers and providers.
Parabilis Medicines is developing a new type of peptide drug capable of hitting elusive disease targets inside cells. Cancer is the biotech’s initial focus, and the IPO cash will support lead program zolucatetide, which is in development for a rare type of tumor with limited treatment options.
Our new report will focus on how people who work for payers are thinking about AI and cybersecurity needs to protect sensitive healthcare data.
A checklist for AI readiness from Nordic aims to help healthcare organizations avoid failure.
Researchers from UC San Diego, Johns Hopkins and UPMC have developed an AI-powered CPR coaching tool called ChatCPR that outperformed human 911 dispatchers in guiding bystanders through CPR. The team released the tool as an open-source resource, with the hopes that the right companies and emergency-response organizations can deploy it broadly.
IKS Health acquired healthcare AI startup ARAI to strengthen the technology underpinning its automation tools, as well as reduce its dependence on third-party AI models.
Isomorphic Labs’ Series B financing is the second largest ever raised by a biotech startup. Like the largest one, Isomorphic is also opaque about its drug programs.
Midstream Health is taking a bit of a different approach to healthcare AI by focusing on reducing hospitals’ costs rather than boosting their revenue. The startup uses AI to identify savings opportunities across fragmented spending data, which helps health systems like Mount Sinai and CommonSpirit quickly improve their purchasing decisions.
Innovaccer is committing $250 million to expand its AI agent platform, which automates workflows across areas like prior authorization, revenue cycle management and population health. The move comes amid an ongoing debate over whether administrative AI tools can ultimately reduce costs for providers.
HeartFlow, which makes AI tools to analyze cardiac images, sued its rival Cleerly, alleging infringement on six patents. Cleerly is pushing back.
Luminai raised $38 million in Series B funding to scale its AI platform that automates healthcare administrative workflows. The company is working with Cleveland Clinic to expand the use of its system across high-volume processes, starting with referral management.
Mass General Brigham evaluates AI tools by carefully monitoring real-world performance before scaling them system-wide. At HIMSS earlier this month, Rebecca Mishuris, the health system’s chief health information officer and vice president of digital, explained what this process looks like.